Signatures Recent News

Acne Academy Retains Signature Communications - 27/03/2011
Signature Communications has been appointed by the Acne Academy, a collaborative…

Signature Secures Astellas Brief - 27/03/2011
Japanese pharmaceutical giants Astellas have appointed dermatology experts Signature…

Signature Communications lands brief to handle Botox rival - 25/02/2010
Dermatology firm Galderma has turned to Signature Communications to promote…

Basilea Brings in Signature Communications - 08/02/2010
Signature Communications has been brought in to support a medical education…

Sun Smart, Skin Aware - Communiqué - 27/11/2009
Thirty to forty years ago, sun awareness campaigns to convey skin damage did…

Signature Secures Scar Prevention Brief - 03/06/2009
Signature Healthcare Communications has been bought onboard by Cranage Healthcare…

Visit the full news archive

Japanese pharmaceutical giants Astellas have appointed dermatology experts Signature Communications to spearhead its medical education account for their atopic dermatitis treatment Protopic.

The company has charged the agency with implementing a comprehensive medical education programme, specifically targeting GPs and consultant dermatologists. Signature won the account following a competitive pitch which involved at least two other unnamed agencies.

Signature has considerable experience in the dermatology arena.  The agency currently works with the Primary Care Dermatology Society and recently formed Acne Academy, as well as a number of pan-European dermatology companies including Almirall, Galderma and Basilea.

~ ~ ~

Astellas Corporate Profile:  Astellas Pharma Europe Ltd. is a European subsidiary of Tokyo-based Astellas Pharma Inc., a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative, reliable pharmaceutical products. Astellas is focused on five key therapy areas: Transplantation, Urology, Dermatology, Anti-Infectives, and most recently, Pain Management.